Therapy Areas: Cardiovascular
CNSystems Medizintechnik GmbH offers CNAP hemodynamic tests to improve COVID-19 treatment
3 June 2020 -

Hemodynamic company CNSystems Medizintechnik GmbH said on Tuesday that international experts treating COVID-19 patients have concluded that hemodynamic optimization plays an important role in addressing the complex interaction of respiratory and cardiovascular.

The company now offers the CNAP customized solution to endorse diagnostic functional and therapeutic guidance hemodynamic tests, as recommended by general guidelines and frontline experts from COVID-19. CNAP is a non-invasive, easy-to-use and accurate solution that only uses a finger sensor to measure all parameters in real time. Hemodynamics are reportedly the dynamics of blood flow.

In the recent educational webinars organized by the European Society for Intensive Care Medicine (ESICM), experts from countries affected by COVID-19 emphasized the use of hemodynamic control of COVID-19 patients. The hemodynamic optimization has proven to be extremely important, since instabilities cause a large number of complications in this group of patients.



Related Headlines